Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved Optune Pax (R) for the treatment of adult patients with locally advanced pancreatic cancer concomitant ...
Optune Pax concomitant with gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancerPhase 3 PANOVA-3 trial showed a ...
Beautiful hotels are peppered across various neighbourhoods in one of the most beautiful cities of India. In Central Delhi, ...
High-resolution in vivo imaging of gene expression is not possible in opaque animals by existing techniques. Here we present a new approach for obtaining such images by magnetic resonance imaging (MRI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results